Form D · Other Technology
SRA Health, Inc.
Kansas City, MO · CIK 0001754829
Offering snapshot reported Feb 2, 2026 · SEC filing
- Reported sold
- $2.92M Offering amount: $3.19M
- Investors reported
- 44 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 2, 2026 | Initial | $2,919,636 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-572073
$726,441 of the Total Offering Amount and Total Amount Sold are new cash investments, $273,554 of the Total Offering Amount is new cash investments that remain to be sold and the remainder is the conversion of existing convertible securities.
Source: Form D, filed Feb 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Biehl | Director |
| Steven Coen | Director, Executive |
| Valeed Malik | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4050 Pennsylvania Ave Ste 115 #78
Kansas City, MO, 64111-3041
Kansas City, MO, 64111-3041